-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIDGEBIO PHARMA, - TO SUBMIT MAA FOR ORAL INFIGRATINIB IN ACHONDROPLASIA TO EMA IN Q4 2026

Reuters·09/09/2026 08:00:00

Please log in to view news